This weekend we have the ASCO-GI biomedical meeting happening with some new data coming. See our full ASCO-GI post with catalyst readouts. See below for a table full of major events you should keep an eye on that are expected in the coming weeks.

As we have reached the end of February, we review moves from smid-cap biopharma companies during this past week as well as for the month...